OTCMKTS:INLX Intellinetics (INLX) Stock Forecast, Price & News $3.46 -0.04 (-1.14%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range$3.43▼$3.5050-Day Range$3.46▼$4.2552-Week Range$3.25▼$11.94Volume1,501 shsAverage Volume4,603 shsMarket Capitalization$14.08 millionP/E Ratio115.33Dividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest About Intellinetics (OTCMKTS:INLX) StockIntellinetics, Inc. is a holding company, which engages in the provision of document services and software solutions to private and public sectors. It operates through the Document Management and Document Conversion segments. The Document Management segment allows customers to capture and manage all documents across operations. The Document Conversion segment assists clients as a part of overall document strategy to convert documents from one medium to another, predominantly paper to digital, including migration to software solutions. The company was founded by A. Michael Chretien, Matthew L. Chretien, and Thomas D. Moss on October 3, 1997 and is headquartered in Columbus, OH.Read More Receive INLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter. Email Address INLX Stock News HeadlinesMay 25, 2023 | americanbankingnews.comQ2 2023 Earnings Estimate for Intellinetics, Inc. Issued By Taglich Brothers (OTCMKTS:INLX)May 15, 2023 | msn.comIntellinetics GAAP EPS of $0.03 beats by $0.01, revenue of $4.19M beats by $0.24MJune 9, 2023 | UNKNOWN (Ad)This NASDAQ Stock Is The Amazon Of Medical SupplyThis Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More NowMay 15, 2023 | finance.yahoo.comIntellinetics Grows Revenues 55% in Q1 2023May 8, 2023 | finance.yahoo.comIntellinetics to Host First Quarter 2023 Financial Results Conference Call on May 15April 24, 2023 | finance.yahoo.comIntellinetics to Participate at 2023 MSBO Annual Conference & Exhibit ShowApril 20, 2023 | barrons.comIntellinetics to Participate at Taglich Brothers 19(th) Annual Investment ConferenceApril 18, 2023 | finance.yahoo.comIntellinetics to Participate at Taglich Brothers 19th Annual Investment ConferenceJune 9, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.April 4, 2023 | americanbankingnews.comIntellinetics, Inc. Forecasted to Post Q1 2023 Earnings of $0.02 Per Share (OTCMKTS:INLX)April 3, 2023 | finance.yahoo.comIntellinetics Named One of The Americas' Fastest Growing Companies by the Financial TimesApril 2, 2023 | americanbankingnews.comQ1 2024 Earnings Estimate for Intellinetics, Inc. (OTCMKTS:INLX) Issued By Taglich BrothersMarch 31, 2023 | americanbankingnews.comIntellinetics (OTCMKTS:INLX) Receives Speculative Buy Rating from Taglich BrothersMarch 31, 2023 | americanbankingnews.comTaglich Brothers Reaffirms Speculative Buy Rating for Intellinetics (OTCMKTS:INLX)March 30, 2023 | finance.yahoo.comIntellinetics, Inc. (PNK:INLX) Q4 2022 Earnings Call TranscriptMarch 29, 2023 | americanbankingnews.comIntellinetics (OTCMKTS:INLX) Announces Earnings Results, Beats Estimates By $0.03 EPSMarch 27, 2023 | finance.yahoo.comIntellinetics Grows Annual Revenue 22% in 2022March 27, 2023 | markets.businessinsider.comHere's what Wall Street expects from Intellinetics's earningsMarch 20, 2023 | finance.yahoo.comIntellinetics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on March 27March 3, 2023 | ca.finance.yahoo.comIntellinetics, Inc. (INLX) Interactive Stock Chart - Yahoo FinanceFebruary 23, 2023 | msn.comBrightcove (BCOV) Reports Q4 Loss, Lags Revenue EstimatesFebruary 16, 2023 | finance.yahoo.comIntellinetics to Participate in Winter Wonderland Best Ideas Virtual Investor ConferenceFebruary 14, 2023 | finance.yahoo.comIntellinetics Completes Digital Conversion of Vital Records for Garden City, MichiganJanuary 26, 2023 | finance.yahoo.comIntellinetics to Ring Closing Bell at The New York Stock ExchangeDecember 20, 2022 | finance.yahoo.comIntellinetics Announces Retirement of Vice President of Products and Services Terry BuchananDecember 5, 2022 | finance.yahoo.comIntellinetics Announces New Release of YellowFolderNovember 16, 2022 | finance.yahoo.comIntellinetics Names Experienced Audit and Reporting Expert John Guttilla to Board of DirectorsSee More Headlines INLX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INLX Company Calendar Last Earnings5/15/2023Today6/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Prepackaged software Sub-IndustryN/A SectorComputer and Technology Current SymbolOTCMKTS:INLX CUSIPN/A CIK1081745 Webwww.intellinetics.com Phone(614) 921-8170FaxN/AEmployees93Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E Ratio115.33 Forward P/E Ratio26.62 P/E GrowthN/ANet Income$20,000.00 Net Margins1.02% Pretax Margin1.01% Return on Equity5.92% Return on Assets2.52% Debt Debt-to-Equity Ratio0.32 Current Ratio0.84 Quick Ratio0.82 Sales & Book Value Annual Sales$14.02 million Price / Sales1.00 Cash Flow$0.25 per share Price / Cash Flow14.12 Book Value$2.10 per share Price / Book1.65Miscellaneous Outstanding Shares4,070,000Free Float3,746,000Market Cap$14.08 million OptionableNot Optionable Beta0.38 Key ExecutivesJames F. DeSocioPresident, Chief Executive Officer & DirectorMike BeckVice President-OperationsJoe SpainChief Financial Officer & TreasurerMatt ChretienSecretary, Director, CTO & Chief Strategy OfficerThomas D. MossVice President-Research & DevelopmentKey CompetitorsauthIDNASDAQ:AUIDIveda SolutionsOTCMKTS:IVDABridgeline DigitalNASDAQ:BLINGSE SystemsNASDAQ:GVPTaopingNASDAQ:TAOPView All CompetitorsInstitutional OwnershipSusquehanna International Group LLPBought 17,691 shares on 5/16/2023Ownership: 0.434%View All Institutional Transactions INLX Stock - Frequently Asked Questions Should I buy or sell Intellinetics stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Intellinetics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INLX shares. View INLX analyst ratings or view top-rated stocks. How have INLX shares performed in 2023? Intellinetics' stock was trading at $4.27 at the beginning of the year. Since then, INLX stock has decreased by 19.0% and is now trading at $3.46. View the best growth stocks for 2023 here. How were Intellinetics' earnings last quarter? Intellinetics, Inc. (OTCMKTS:INLX) released its quarterly earnings data on Monday, May, 15th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.01. The company had revenue of $4.19 million for the quarter, compared to the consensus estimate of $3.95 million. Intellinetics had a trailing twelve-month return on equity of 5.92% and a net margin of 1.02%. What other stocks do shareholders of Intellinetics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Intellinetics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Kopin (KOPN), Onconova Therapeutics (ONTX), OPKO Health (OPK), Precipio (PRPO), Selecta Biosciences (SELB), Sierra Oncology (SRRA) and T2 Biosystems (TTOO). What is Intellinetics' stock symbol? Intellinetics trades on the OTCMKTS under the ticker symbol "INLX." Who are Intellinetics' major shareholders? Intellinetics' stock is owned by a number of retail and institutional investors. Top institutional investors include Susquehanna International Group LLP (0.43%). View institutional ownership trends. How do I buy shares of Intellinetics? Shares of INLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Intellinetics' stock price today? One share of INLX stock can currently be purchased for approximately $3.46. How much money does Intellinetics make? Intellinetics (OTCMKTS:INLX) has a market capitalization of $14.08 million and generates $14.02 million in revenue each year. The company earns $20,000.00 in net income (profit) each year or $0.03 on an earnings per share basis. How can I contact Intellinetics? Intellinetics' mailing address is 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228. The official website for the company is www.intellinetics.com. The company can be reached via phone at (614) 921-8170 or via email at contactus@intellinetics.com. This page (OTCMKTS:INLX) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellinetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.